U.S. Senator Pat Toomey (R-Pa.) released the following statement today on the bipartisan passage of the Food and Drug Administration Safety and Innovation Act (S. 2516), which passed the Senate 96-1.
"I am very pleased to join with members of both parties in supporting the passage of the Food and Drug Administration Safety and Innovation Act. This important bill will renew two user fee programs and create two more, ensuring that the FDA has the necessary resources to review and approve new medical products. This legislation also improves the submission process for medical device manufacturers and expedites the review of certain drugs targeting serious or life-threatening diseases," Sen. Toomey said. "The passage of this bill shows what Congress can accomplish when we work together in a bipartisan manner for the good of the American people."